Amanote Research
Register
Sign In
The Effect on Gastric Emptying of Telaprevir-Based Triple Therapy for Chronic Hepatitis C Patients
doi 10.17352/2455-2283.000003
Full Text
Open PDF
Abstract
Available in
full text
Date
July 27, 2015
Authors
M Arai
Publisher
Peertechz Publications Private Limited
Related search
Telaprevir-Based Triple Therapy for Hepatitis C Null Responders Among Living Donor Liver Transplant Recipients
BioScience Trends
Biochemistry
Health
Medicine
Genetics
Molecular Biology
Chronic Hepatitis C Treated With Telaprevir-Based Triple Therapy Following Interferon Combination Chemotherapy for Non-Hodgkin Lymphoma: A Case Report
Acta Hepatologica Japonica
Hepatology
Prediction of Anemia in Triple Therapy With Peginterferon ^|^alpha;-2b, Ribavirin, and Telaprevir for Patients With Chronic Hepatitis C From the Viewpoint of Renal Function
Acta Hepatologica Japonica
Hepatology
Effect of Fibrosis on Adverse Events in Patients With Hepatitis C Treated With Telaprevir
Alimentary Pharmacology and Therapeutics
Hepatology
Pharmacology
Gastroenterology
Prediction of Treatment Efficacy and Telaprevir-Resistant Variants After Triple Therapy in Patients Infected With Hepatitis C Virus Genotype 1
Journal of Clinical Microbiology
Microbiology
Comparative Effectiveness of Triple Therapy Versus Dual Therapy for Chronic Hepatitis C Virus Infection in Kazakhstan
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Telaprevir-Based Triple Therapy for Re-Treatment Chronic HCV Patients With Genotype 1, Including the Null-Response: A Single Center Experience From Turkey
Virology: Research and Reviews
Boceprevir and Telaprevir for the Treatment of Chronic Hepatitis C: Safety Management in Clinical Practice
Liver International
Hepatology
Telaprevir in a Patient With Chronic Hepatitis C and Cryoglobulinemic Glomerulonephritis
Antiviral Therapy
Infectious Diseases
Pharmacology
